FDA Approved: TACROLIMUS — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approves a supplemental application for tacrolimus from Accord Healthcare Inc., resulting in updated labeling and/or indications for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

SUPPL AP for TACROLIMUS (TACROLIMUS)